Help every eligible patient learn about a trial that fits.
- Join providers, sponsors, EHR vendors, and CMS each week.
- Make eligibility criteria readable by matching systems.
- Follow what the workgroup learns, session by session.
CareSet co-chairs CMS Clinical Trial Matching Workgroup
CareSet uses longitudinal Medicare FFS claims to show sponsors and CROs which sites and communities of practice treat the patients your protocol needs, at the point in their care when they can still qualify.
of Medicare FFS Parts A, B, and D
of longitudinal data
refresh at the NPI and facility level
DUA with CMS since 2015
Sponsors tend to return to principal investigators they already know, even when a PI is a poor fit for the disease and the treatment being tested. Oncology trials can run at sites that never enroll a single patient.
When a general or subspecialty oncologist does not match the indication and regimen, eligible patients either never come to that practice or arrive after they have exhausted the options that would have qualified them at prescreening.
What Claims Show
Frontline physicians. Claims identify the physicians who start patients on innovative treatments in the front line, which raises the chance that a patient can still enter a first-line trial.
Referral patterns. Claims show how patients move between practices and which communities of practice send patients to each site.
The full census. CareSet works from 100% of Medicare FFS claims, a census of the patient journey rather than a sample, including academic medical centers missing from standard commercial data.
Step 1
Share the indication, line of therapy, and the eligibility criteria that matter most. We translate them into the diagnosis, procedure, and treatment codes that describe that patient in Medicare FFS claims.
Step 2
We trace those patients across 100% of Medicare FFS to the physicians and facilities treating them, including frontline physicians already using innovative regimens, and map the referral networks that send patients to each site.
Step 3
We assess your proposed sites against that evidence and surface alternatives, so every site on the final list treats the patients your protocol needs before activation begins.
| Site | Setting | Region | Medicare FFS patients with the indication, last 12 months | Frontline use of the study regimen class | Referring practices | Patients within 4 hours | Rating |
|---|---|---|---|---|---|---|---|
| Site A | Community oncology practice | Southeast | 410 | High | 38 | 2,900 | Strong fit |
| Site B | Academic medical center | Midwest | 265 | Moderate | 22 | 3,400 | Strong fit |
| Site C | Hospital outpatient department | Mountain West | 140 | High | 15 | 1,100 | Good fit |
| Site D | General oncology group | Northeast | Present (11 or fewer) | Low | 4 | 850 | Review |
Illustrative example with fictional sites and values. Deliverables are at the NPI and facility level, and counts of 11 or fewer are reported as present, following CMS cell-size rules.
HHS Operation TrialBlazer and the CMS Health Tech Ecosystem Clinical Trial Matching Pledge are working to close the gap between patients and the trials that fit them. CareSet signed the pledge as an early adopter, and CareSet CEO and co-founder Ashish Patel co-chairs the Clinical Trial Matching Workgroup.
A trial reaches patients through the sites that treat them, so the sites you select decide which patients have the chance to enroll.
What the workgroup is learning, session by session.
Read the pledge on CMS.gov.
Tell us the indication and line of therapy, and our team will show you where those patients are treated.
Complete the form below and we will email the white paper PDF to you.
Thank you. The white paper has been emailed to you and will arrive shortly.
Upcoming Events